BioCryst Pharmaceuticals | BCRX - 운영 비용

주가
8.62
매일 변경
-0.28 -3.15%
매월
-12.84%
매년
-13.54%
Q2 예상
9.00




운영 비용 변화 날짜
Alnylam Pharmaceuticals USD 898.54M 66.78M 2026-03
BioCryst Pharmaceuticals USD -553.84M 700.01M 2026-03
Chugai Pharma JPY 162.98B 14.31B 2026-03
Daiichi Sankyo JPY 468.57B 15.34B 2025-12
DBV Technologies USD 37.05M 4.06M 2025-09
Enanta Pharmaceuticals USD 126.59M 346.51M 2025-12
Gilead Sciences USD 23.52B 18.55B 2026-03
GlaxoSmithKline GBP 5.34B 1.85B 2026-03
Glaxosmithkline GBP 9.17B 1.4B 2025-12
Incyte USD 5.62B 4.5B 2026-03
Ionis Pharmaceuticals USD 364M 54M 2026-03
Karyopharm Therapeutics USD 51.92M 9.9M 2025-12
Neurocrine Biosciences USD 599.9M 22.3M 2026-03
Novavax USD 126.2M 23.62M 2025-12
PTC Therapeutics USD 226.66M 19.64M 2026-03
Regeneron Pharmaceuticals USD 31.42B 28.44B 2026-03
Roche Holding CHF 21.01B 10.84B 2025-12
Sarepta Therapeutics USD 372.37M 480.65M 2026-03
Ultragenyx Pharmaceutical USD 305M 16M 2026-03
Vertex Pharmaceuticals USD 1.85B 78.6M 2026-03